Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 10:59 AM ET


Company Overview of Blueprint Medicines Corporation

Executive Profile

Daniel S. Lynch M.B.A

Executive Chairman, Member of Audit Committee and Member of Compensation Committee, Blueprint Medicines Corporation
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 14 different industries.

See Board Relationships


Mr. Daniel S. Lynch, also known as Dan, M.B.A has been the President and Chief Executive Officer of IVREA Pharmaceuticals Inc. since February 1, 2007. Mr. Lynch has been a Venture Partner at Third Rock Ventures, LLC since May 14, 2013. He supports the commercial and business development of existing portfolio companies and serves as a strategic advisor across the portfolio. He was an Entrepreneur-in-Residence of Third Rock Ventures, LLC from joining in May 2011 to May ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-374-7580
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director
Member of The Board of Directors
Director, Member of Audit Committee and Director of US Oncology Inc
Chairman, Chairperson of Compensation Committee and Member of Audit Committee
Executive Chairman
Executive Chairman, Member of Audit Committee and Member of Compensation Committee
Chairman, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee


Wesleyan University
Colgate W. Darden Graduate School of Business Administration

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$130,000
Total Calculated Compensation$130,000

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Blueprint Medicines Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at